Skip to Main content Skip to Navigation
Journal articles

The antibiotic bedaquiline activates host macrophage innate immune resistance to bacterial infection

Abstract : Antibiotics are widely used in the treatment of bacterial infections. Although known for their microbicidal activity, antibiotics may also interfere with the host's immune system. Here, we analyzed the effects of bedaquiline (BDQ), an inhibitor of the mycobacterial ATP synthase, on human macrophages. Genome-wide gene expression analysis revealed that BDQ reprogramed cells into potent bactericidal phagocytes. We found that 579 and 1,495 genes were respectively differentially expressed in naive- and M. tuberculosis-infected macrophages incubated with the drug, with an over-representation of lysosome-associated genes. BDQ treatment triggered a variety of antimicrobial defense mechanisms, including phagosome-lysosome fusion, and autophagy. These effects were associated with activation of transcription factor EB, involved in the transcription of lysosomal genes, resulting in enhanced intracellular killing of different bacterial species that were naturally insensitive to BDQ. Thus, BDQ could be used as a host-directed therapy against a wide range of bacterial infections.
Complete list of metadata

Cited literature [70 references]  Display  Hide  Download
Contributor : Ludovic Tailleux Connect in order to contact the contributor
Submitted on : Saturday, June 20, 2020 - 5:36:42 PM
Last modification on : Tuesday, April 12, 2022 - 4:28:03 PM


The antibiotic bedaquiline act...
Publication funded by an institution


Distributed under a Creative Commons Attribution 4.0 International License



Alexandre Giraud-Gatineau, Juan Manuel Coya, Alexandra Maure, Anne Biton, Michael Thomson, et al.. The antibiotic bedaquiline activates host macrophage innate immune resistance to bacterial infection. eLife, eLife Sciences Publication, 2020, 9, pp.e55692. ⟨10.7554/eLife.55692⟩. ⟨pasteur-02876140⟩



Record views


Files downloads